Home/Filings/4/0001104659-23-023508
4//SEC Filing

Rivera Victor 4

Accession 0001104659-23-023508

CIK 0001745020other

Filed

Feb 20, 7:00 PM ET

Accepted

Feb 21, 7:03 AM ET

Size

5.4 KB

Accession

0001104659-23-023508

Insider Transaction Report

Form 4
Period: 2023-02-17
Rivera Victor
Chief Scientific Officer
Transactions
  • Award

    Stock Option (right to buy)

    2023-02-17+97,50097,500 total
    Exercise: $11.42Exp: 2033-02-17Common Stock (97,500 underlying)
Footnotes (1)
  • [F1]The options are subject to a service-based vesting requirement, which shall be satisfied over a four-year period with 25% of the options vesting on February 17, 2024 and 1/48th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer.

Issuer

Theseus Pharmaceuticals, Inc.

CIK 0001745020

Entity typeother

Related Parties

1
  • filerCIK 0001876623

Filing Metadata

Form type
4
Filed
Feb 20, 7:00 PM ET
Accepted
Feb 21, 7:03 AM ET
Size
5.4 KB